Chattanooga Division Of DJO Receives FDA Market Clearance For Shortwave Diathermy For Pain Relief, Joint Contractures, And Inflammatory Conditions

Main Category: Bones / Orthopedics
Also Included In: Pain / Anesthetics;  Regulatory Affairs / Drug Approvals
Article Date: 19 Apr 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (3 votes)

Healthcare Prof:not yet rated


DJO Incorporated, a global provider of medical devices that deliver solutions for musculoskeletal health, vascular health, and pain management, announced that its Chattanooga business has received 510-K clearance from the U.S. FDA to market and sell the Intelect® SWD Shortwave Diathermy device in the United States. Plans are underway to bring the unit to market in Spring 2009.

"Bringing continuous innovation to the clinical rehabilitation market is the cornerstone of our brand," says Ed Dunlay, vice president product development & clinical education for Chattanooga. "The Intelect SWD 100 has been designed with voice of the customer research, which we used to enhance an already proven therapeutic modality."

Chattanooga's new Intelect SWD innovations include a touch screen interface and onboard software that allows therapists to customize their patient's therapy. Chattanooga's Shortwave Diathermy unit is the only domestic shortwave product to operate via a touch screen interface. The unit is very simple to use. Therapists can begin treatment in as few as two touches to the home screen.

Shortwave Diathermy is a clinical treatment modality that provides a superior form of deep tissue heating. Indications for use include: pain relief, reduction of muscle spasm, decreasing joint stiffness, contractures, increased blood flow, chronic inflammatory conditions, bursitis, tenosynovitis, synovitis and chronic inflammatory pelvic disease.

About Chattanooga

As part of DJO Incorporated, Chattanooga is the world's largest manufacturer of clinical rehabilitation equipment and supplies for treating skeletal, muscular, neurological and soft tissue disorders. Our popular brands include the Hydrocollator hot and cold therapy products; Adapta® treatment platforms; a comprehensive family of Intelect® and Vectra® Genisys electrotherapy which include ultrasound, laser and light therapy; Triton® DTS traction systems; and OptiFlex® continuous passive motion devices.

Our over 300 products are found in hospitals, clinics and doctors' offices throughout the world and provide healthcare professionals with the solutions they need for better patient outcomes. Chattanooga products are sold through a network of dealers/distributors. Chattanooga maintains offices in Chattanooga, Tennessee, with facilities in Belgium, Canada and Australia. As part of DJO, Chattanooga is headquartered in Vista, California.

About DJO Incorporated

DJO is a leading global developer, manufacturer and distributor of high-quality medical devices that provide solutions for musculoskeletal health, vascular health and pain management. The Company's products address the continuum of patient care from injury prevention to rehabilitation after surgery, injury or from degenerative disease. Our products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals. In addition, many of the Company's medical devices and related accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The Company's product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular systems, electrical stimulators used for pain management and physical therapy products. The Company's surgical division offers a comprehensive suite of reconstructive joint products for the hip, knee and shoulder. DJO's products are marketed under the brands Aircast®, DonJoy®, ProCare®, CMF™, Empi®, Saunders®, Chattanooga, DJO Surgical, Cefar®-Compex® and Ormed®. DJO uses its website as a channel of distribution of material Company information. Financial and other material information regarding the Company is routinely posted and accessible at http://www.DJOglobal.com.

Source
DJO Incorporated

Article adapted by Medical News Today from original press release.
Visit our bones / orthopedics section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
DJO Incorporated. "Chattanooga Division Of DJO Receives FDA Market Clearance For Shortwave Diathermy For Pain Relief, Joint Contractures, And Inflammatory Conditions." Medical News Today. MediLexicon, Intl., 19 Apr. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/146546.php>

APA
DJO Incorporated. (2009, April 19). "Chattanooga Division Of DJO Receives FDA Market Clearance For Shortwave Diathermy For Pain Relief, Joint Contractures, And Inflammatory Conditions." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/146546.php.

Please note: If no author information is provided, the source is cited instead.


Bones / Orthopedics

Most Popular Articles



Follow Our Bones News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Bones / Orthopedics Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »